We develop advanced solutions in health and medicine.
Innovation in Medical Research for Women's Healthcare
We develop advanced solutions in health and medicine.
KBK Medical Solutions
Mission
Our mission is to advance maternal and neonatal health by developing innovative, evidence-based solutions for two of the most pressing obstetric challenges: postpartum hemorrhage and preterm premature rupture of membranes (PPROM). We are committed to translating cutting-edge research into clinical practices that save lives, reduce healthcare costs, and improve quality of care worldwide.
Vision
Our vision is to become a global reference in obstetric innovation, leading the development of scalable, accessible, and high-impact interventions. We aim to create a future where preventable maternal and neonatal complications are drastically reduced, ensuring healthier outcomes for mothers and babies across diverse healthcare settings.
Team
- Dr. Juan Pedro Kusanovic – Principal Investigator & Research Leader
Internationally recognized in maternal-fetal medicine, Dr. Kusanovic provides scientific leadership and strategic direction for the project. His expertise in translational obstetrics ensures that innovation is grounded in clinical relevance and global applicability.
- Multidisciplinary & International Collaboration
The project brings together experts in:
- Maternal-Fetal Medicine & Obstetrics – clinical insights and patient care strategies.
- Biomedical Engineering – device design and validation for intrauterine balloon innovation.
- Neonatology – ensuring improved neonatal outcomes in PPROM-related prematurity.
- Molecular Biology & Biomarkers – research into early detection and predictive tools.
- Health Economics & Policy – evaluating cost-effectiveness and system-level impact.
- International Partners – ensuring applicability across high-, middle-, and low-resource settings.
- Maternal-Fetal Medicine & Obstetrics – clinical insights and patient care strategies.
This multidisciplinary, international team ensures a comprehensive approach, combining clinical, technological, biological, and economic expertise to maximize impact.
Quantified Social Impact
Background
Obstetric complications remain a critical challenge in Europe and the United States:
- Postpartum Hemorrhage (PPH): the leading cause of maternal mortality worldwide.
- Preterm Premature Rupture of Membranes (PPROM): responsible for up to 40% of preterm births.
Both conditions carry a high burden in terms of mortality, morbidity, and healthcare costs.
Scope of the Problem
- Annual births:
- Europe: ~3.67 million
- United States: ~3.59 million
- Estimated incidence:
- PPH requiring intrauterine balloon: ≈100,000 women/year
- PPROM: ≈150,000 pregnancies/year
Current Economic Impact
- Intrauterine balloon / PPH:
- Severe cases may add $10,000 USD in hospital costs (ICU, transfusions, surgery).
- Avoidable healthcare burden: ≈ $1 billion USD/year.
- Severe cases may add $10,000 USD in hospital costs (ICU, transfusions, surgery).
- PPROM:
- Associated prematurity: $30,000–100,000 USD per case (NICU + complications).
- Avoidable healthcare burden: ≈ $0.5–1.5 billion USD/year.
- Associated prematurity: $30,000–100,000 USD per case (NICU + complications).
Research and Innovation Potential
- Intrauterine balloon: development of affordable, easy-to-use devices deployable across all hospital levels, reducing the need for hysterectomy and mortality risk.
- PPROM: early biomarkers, new therapies to prolong latency, and preventive strategies to reduce preterm birth rates.
Expected Return on Investment (ROI)
- Effective solutions could reduce the combined economic burden of both conditions by more than $2 billion USD annually across Europe and the United States.
- Additional benefits: reduced maternal and neonatal mortality, improved quality of life, and stronger healthcare systems.
Conclusion
A research project targeting postpartum hemorrhage (intrauterine balloon) and PPROM represents not only a clinical breakthrough but also a highly cost-effective strategy for high-income healthcare systems.
📢 Investing in obstetric innovation saves lives, reduces costs, and creates sustainable social impact.